000 02078cam  2200349za 4500
0019.842534
003CaOODSP
00520221107152337
007cr |||||||||||
008170828s2017    onc     ob   f000 0 eng d
022 |z1925-0932
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-25/2017-13E-PDF|zH113-25/2017-13E
24500|aAzamethiphos |h[electronic resource].
260 |aOttawa : |bHealth Canada, Pest Management Regulatory Agency, |c2017.
300 |a26 p.
4901 |aRegistration decision, |x1925-0940 ; |vRD2017-13
500 |aIssued also in French under title: Azaméthiphos.
500 |aCover title.
500 |a"15 August 2017.”
504 |aIncludes bibliographical references.
520 |a“Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is granting full registration for the sale and use of Azamethiphos Technical and Salmosan Vet containing the technical grade active ingredient azamethiphos to control sea lice on farmed Atlantic salmon. This decision is consistent with the Proposed Registration Decision PRD2016-25, Azamethiphos, which contains a detailed evaluation of the information submitted in support of this registration. The evaluation found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. See Appendix I for a summary of comments received during the consultation process as well as the PMRA’s response to these comments"--p. 1.
530 |aIssued also in print format.
69207|2gccst|aInsecticides
69207|2gccst|aCertification
69207|2gccst|aToxicology
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tAzaméthiphos |w(CaOODSP)9.842535
830#0|aRegistration decision,|x1925-0940 ; |vRD2017-13|w(CaOODSP)9.505184
85640|qPDF|s537 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-25/H113-25-2017-13-eng.pdf